ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
iShares Neuroscience and Healthcare ETF
36.20
0.0000
成交量：
138
成交額：
5,012.85
市值：
723.97萬
市盈率：
- -
高：
36.20
開：
36.20
低：
36.20
收：
36.20
52周最高：
43.01
52周最低：
25.42
股本：
20.00萬
流通股本：
20.00萬
量比：
0.37
換手率：
0.07%
股息：
0.32
股息率：
0.88%
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
港股異動 | 英硅智能(03696)升逾9% ISM8969/HT-001已獲NMPA臨床試驗批件 擬用於帕金森病治療
智通财经
·
08/07
Praxis Precision Medicines發布公司動態及2026年第二季度財務報告
美股速递
·
08/06
Scholar Rock第二季度淨虧損收窄；FDA審查取得進展
路透中文
·
08/06
北京海淀加速打造腦機接口新高地 核心企業佔全國近60%
金吾财讯
·
08/06
北京海淀加速打造腦機接口新高地 核心企業佔全國近60%
智通财经
·
08/06
北京海淀加速打造腦機接口新高地 核心企業佔全國近60%
央视
·
08/06
蚌埠市腦機接口科技發展公司登記成立
智通财经
·
08/06
Dianthus Therapeutics 披露截至2026年6月30日現金儲備達12億美元，預期運營資金可持續至2030年
美股速递
·
08/05
Dianthus Therapeutics 旗下 Dnth312 靶向抑制 Ac1s 與 Baff/April 通路，佈局自身免疫疾病領域
美股速递
·
08/04
Dianthus Therapeutics：DNTH312在非人靈長類模型中展現與Povetacicept相當的免疫球蛋白降低效果
美股速递
·
08/04
宇樹科技早期投資人，盯上了成都腦機接口公司
每日经济新闻
·
08/04
多地密集下注腦機接口產業
智通财经
·
08/04
3.3億！中國腦機接口最大天使輪融資完成
智东西
·
08/04
腦機接口板塊短線拉升，創新醫療漲停
智通财经
·
08/04
規範產業發展 提升生活品質
中国质量报
·
08/04
女子因車禍導致雙手及下肢癱瘓，安徽為其開出全省首張腦機接口「處方」
合肥日报
·
08/03
腦機接口企業主動科技完成3.3億元天使輪融資
智通财经
·
08/03
階梯醫療：植入式腦機接口取得重要進展，已幫多位高位截癱者重返職場
市场资讯
·
08/01
早安安徽 | 安徽首張腦機接口處方開出併成功手術！
安徽发布
·
08/01
艾伯維2026年第二季度財報：免疫學與神經科學推動營收增長10.2%
TradingKey中文
·
07/31
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/IBRN/news?page=6"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","market":"US","secType":"STK","nameCN":"iShares Neuroscience and Healthcare ETF","latestPrice":36.1985,"timestamp":1789571091263,"preClose":36.1985,"halted":0,"volume":138,"delay":0,"changeRate":0,"floatShares":200000,"shares":200000,"eps":0,"marketStatus":"交易中","change":0,"latestTime":"09-16 11:05:33 EDT","open":36.1985,"high":36.1985,"low":36.1985,"amount":5012.846964,"amplitude":0,"askPrice":36.38,"askSize":400,"bidPrice":36.13,"bidSize":400,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":36.1985,"sharesOutstanding":150000,"nav":37.284354,"aum":7456870.8,"dividendRate":0.008801,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":36.35,"preClose":36.1985,"latestTime":"17:17 EDT","volume":7,"amount":253.794,"timestamp":1789507022693,"change":0.1515,"changeRate":0.004185,"amplitude":0},"volumeRatio":0.369464,"impliedVol":0.1976,"impliedVolPercentile":0.9124},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","floatShares":200000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.369464,"shares":200000,"dividePrice":0.3186,"high":36.1985,"amplitude":0,"preClose":36.1985,"low":36.1985,"week52Low":25.4196,"pbRate":"--","week52High":43.01,"institutionHeld":0,"latestPrice":36.1985,"eps":0,"divideRate":0.008801,"volume":138,"delay":0,"ttmEps":0,"open":36.1985,"prevYearClose":32.3193,"prevWeekClose":37.4262,"prevMonthClose":38.9601,"prevQuarterClose":38.8263,"fiveDayClose":37.9959,"twentyDayClose":39.7665,"sixtyDayClose":36.6691},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBRN\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"IBRN","amount":0.319807,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2024-12-17","symbol":"IBRN","amount":0.10114,"announcedDate":"2024-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2023-12-20","symbol":"IBRN","amount":0.006303,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"},{"date":"2023-06-07","symbol":"IBRN","amount":0.008241,"announcedDate":"2023-05-12","type":"dividend","market":"US","newRecordDate":"2023-06-08","defaultRemindTime":1686144600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-06-13","payableDate":"2023-06-08","currency":"USD","dateTimestamp":1686110400000,"payDate":"2023-06-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBRN\",market:\"US\",,,undefined,":[{"executeDate":"2023-06-07","recordDate":"2023-06-08","paymentDate":"2023-06-13","value":0.008241,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.006303,"currency":"USD"},{"executeDate":"2024-12-17","recordDate":"2024-12-17","paymentDate":"2024-12-20","value":0.10114,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-19","value":0.319807,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBRN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBRN\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657691079","title":"港股異動 | 英硅智能(03696)升逾9% ISM8969/HT-001已獲NMPA臨床試驗批件 擬用於帕金森病治療","url":"https://stock-news.laohu8.com/highlight/detail?id=2657691079","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657691079?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 14:04","pubTimestamp":1786082650,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，英硅智能涨超9%，截至发稿，涨8.1%，报44.3港元，成交额5.41亿港元。消息面上，近日，据英硅智能官微消息，英硅智能宣布，公司与衡泰生物共同开发的创新口服NLRP3抑制剂ISM8969/HT-001已获得中国国家药品监督管理局临床试验批件，拟用于帕金森病治疗。此前，英硅智能于2026年1月宣布与复星健康资本旗下深圳鹏复基金与复星医药的被投企业衡泰生物达成独家授权与合作协议，共同推进ISM8969/HT-001的全球开发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477206.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1612","MDTX","01611","03696","BK1167","BK4585","BK1141","BK4588","BMED","IBBJ","IBRN","KCAI","BK4181","PSYK","VXUS","BK4218","HT","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109275243","title":"Praxis Precision Medicines發布公司動態及2026年第二季度財務報告","url":"https://stock-news.laohu8.com/highlight/detail?id=1109275243","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109275243?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 20:02","pubTimestamp":1786017736,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines, Inc. 近日公布了公司最新进展情况，并同时披露了2026年第二季度的财务业绩。此次更新，不仅涵盖了公司运营层面的关键动态，也清晰展示了其截至该季度的财务状况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","IE0009355771.USD","PRAX","LU0320765992.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","IE00BJJMRZ35.SGD","IBRN","BK4139","IE00B4R5TH58.HKD","LU0109394709.USD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657635286","title":"Scholar Rock第二季度淨虧損收窄；FDA審查取得進展","url":"https://stock-news.laohu8.com/highlight/detail?id=2657635286","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657635286?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 19:46","pubTimestamp":1786016772,"startTime":"0","endTime":"0","summary":"BUZZ-Scholar Rock第二季度净亏损收窄；FDA审查取得进展8月6日-** Scholar Rock（SRRK.O）股价在盘前交易中上涨9.69%，至52.51美元** 第二季度每股净亏损为0.84美元，而去年同期为每股0.98美元** 公司表示，其脊髓性肌萎缩症药物的申请正在接受FDA审查，进展持续推进，目前有两家灌装和包装工厂，这意味着有两条独立的审批路径，预计最迟将于9月30日作","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL4T443175:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRRK","THNR","IBRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657685839","title":"北京海淀加速打造腦機接口新高地 核心企業佔全國近60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657685839","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657685839?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 15:53","pubTimestamp":1786002786,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据央视新闻报道，从中关村科学城管委会获悉，北京市海淀区已集聚超30家脑机接口核心企业，占全国近60%，已形成“基础研究-技术攻关-产品研发-临床应用”的全链条创新生态，一个脑机接口新高地正在崛起。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250106/MzNhMjUxNDI3Yzg1Yjg1NGVkN2ZhNDc2YWI2MTA4NTA5OTA5OTQ4.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/MzNhMjUxNDI3Yzg1Yjg1NGVkN2ZhNDc2YWI2MTA4NTA5OTA5OTQ4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987646","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657683924","title":"北京海淀加速打造腦機接口新高地 核心企業佔全國近60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657683924","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657683924?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 15:40","pubTimestamp":1786002058,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657245683","title":"北京海淀加速打造腦機接口新高地 核心企業佔全國近60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657245683","media":"央视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657245683?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 15:40","pubTimestamp":1786002000,"startTime":"0","endTime":"0","summary":"近日记者从中关村科学城管委会获悉，北京市海淀区已集聚超30家脑机接口核心企业，占全国近60%，已形成“基础研究-技术攻关-产品研发-临床应用”的全链条创新生态，一个脑机接口新高地正在崛起。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-06/doc-inimkfvf4674782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657504937","title":"蚌埠市腦機接口科技發展公司登記成立","url":"https://stock-news.laohu8.com/highlight/detail?id=2657504937","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657504937?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 13:42","pubTimestamp":1785994970,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122665642","title":"Dianthus Therapeutics 披露截至2026年6月30日現金儲備達12億美元，預期運營資金可持續至2030年","url":"https://stock-news.laohu8.com/highlight/detail?id=1122665642","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122665642?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:37","pubTimestamp":1785875839,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics 最新披露，截至2026年6月30日，公司持有现金储备高达12亿美元。基于当前资金状况，管理层预期这一现金跑道将支持公司运营直至2030年。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH","IBRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186641577","title":"Dianthus Therapeutics 旗下 Dnth312 靶向抑制 Ac1s 與 Baff/April 通路，佈局自身免疫疾病領域","url":"https://stock-news.laohu8.com/highlight/detail?id=1186641577","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186641577?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 19:11","pubTimestamp":1785841890,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics 公司正着力推进其核心候选药物 Dnth312。该药物旨在通过抑制 Ac1s 以及 Baff/April 这两条关键信号通路，为自身免疫性疾病患者提供全新的治疗策略。此举展现了公司在免疫调节领域的前沿探索与雄心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH","BK4139","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111288447","title":"Dianthus Therapeutics：DNTH312在非人靈長類模型中展現與Povetacicept相當的免疫球蛋白降低效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1111288447","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111288447?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 19:11","pubTimestamp":1785841869,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Inc. 宣布，其候选药物 DNTH312 在非人灵长类动物（NHPs）研究中，显示出与 Povetacicept 相似的免疫球蛋白降低能力。这一发现表明，DNTH312 在调节免疫反应方面具有潜在的治疗价值。该研究的详细数据尚未完全公布，但初步结果已为后续的临床开发提供了有力支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","BK4139","DNTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656534469","title":"宇樹科技早期投資人，盯上了成都腦機接口公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2656534469","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656534469?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 18:02","pubTimestamp":1785837720,"startTime":"0","endTime":"0","summary":"2026年上半年，国内脑机接口领域共发生47起融资事件，披露总金额超53.8亿元，占历史累计融资额近六成。赛道加速，已成共识。“OPC更像外界对瓦博科技早期高效率状态的一个标签，而不是公司的终局组织形态。”瓦博科技的战略定位，很快在市场上得到了验证。四川率先出台了全国首个省级脑机接口医疗服务分类定价标准，张星智认为这是一个重要的制度信号。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-08-04/doc-inimcxxp2096254.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-08-04/doc-inimcxxp2096254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688836","MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656531485","title":"多地密集下注腦機接口產業","url":"https://stock-news.laohu8.com/highlight/detail?id=2656531485","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656531485?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 17:50","pubTimestamp":1785837026,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656534020","title":"3.3億！中國腦機接口最大天使輪融資完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2656534020","media":"智东西","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656534020?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 12:59","pubTimestamp":1785819598,"startTime":"0","endTime":"0","summary":"智东西作者 | 杨京丽编辑 | 李水青智东西8月4日报道，昨日，上海脑机接口企业主动科技宣布完成3.3亿元天使轮融资，创下中国脑机接口领域最大天使轮融资纪录。主动科技CEO吴国佳称，目前“天枢”产品即将以1024通道系统启动临床试验，公司有望成为国内首个开展1024通道侵入式脑机接口临床试验的企业。结语：脑机接口竞争迈向临床转化成立仅半年便获得3.3亿元天使轮融资，主动科技由此获得了扩建研发生产体系、推进临床试验的重要资金支持。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8vJr3zYefp1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656586561","title":"腦機接口板塊短線拉升，創新醫療漲停","url":"https://stock-news.laohu8.com/highlight/detail?id=2656586561","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656586561?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 09:49","pubTimestamp":1785808176,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656588547","title":"規範產業發展 提升生活品質","url":"https://stock-news.laohu8.com/highlight/detail?id=2656588547","media":"中国质量报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656588547?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 07:39","pubTimestamp":1785800340,"startTime":"0","endTime":"0","summary":"这两项标准的实施，有利于提升家用太阳能热水系统的产品质量和能源利用效率，促进市场良性竞争，为百姓提供科学消费指导。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-08-04/doc-inimcatr5756547.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MAKX","IVRS","MNTL","RAYS","IBRN","ARVR","GNSS","BK4020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656015347","title":"女子因車禍導致雙手及下肢癱瘓，安徽為其開出全省首張腦機接口「處方」","url":"https://stock-news.laohu8.com/highlight/detail?id=2656015347","media":"合肥日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656015347?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 12:19","pubTimestamp":1785730786,"startTime":"0","endTime":"0","summary":"王女士曾是一名设计师，一年前因车祸造成颈部脊髓损伤，导致双手及下肢瘫痪。本次手术助手、副主任医师王毅表示，脑机接口技术为这类患者带来了突破性治疗选择。据悉，王女士是全国第三例接受该脑机接口产品植入手术的患者，安徽医科大学第一附属医院是全国第二家正式开展脑机接口手术临床应用的医院。根据术中测试结果，王女士大脑运动信号稳定，质量良好，目前各项生命体征平稳。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8vHnsWiy9I3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656344074","title":"腦機接口企業主動科技完成3.3億元天使輪融資","url":"https://stock-news.laohu8.com/highlight/detail?id=2656344074","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656344074?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 10:50","pubTimestamp":1785725451,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656313399","title":"階梯醫療：植入式腦機接口取得重要進展，已幫多位高位截癱者重返職場","url":"https://stock-news.laohu8.com/highlight/detail?id=2656313399","media":"市场资讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656313399?lang=zh_tw&edition=fundamental","pubTime":"2026-08-01 18:48","pubTimestamp":1785581280,"startTime":"0","endTime":"0","summary":"在阶梯医疗植入式脑机接口临床试验中，通过仅有硬币直径大小的植入体系统，患者靠意念即可流畅操控电脑光标，完成视频、游戏、外卖、网购等日常操作。据悉，阶梯医疗自主研发的256通道植入式脑机接口系统WRS 01，依托行业领先的超柔性电极技术，能够直接采集到单神经元信号，从而令操控性实现质的飞跃。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/china/gncj/2026-08-01/doc-inikvhtw8780133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBRN","159891","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656392040","title":"早安安徽 | 安徽首張腦機接口處方開出併成功手術！","url":"https://stock-news.laohu8.com/highlight/detail?id=2656392040","media":"安徽发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656392040?lang=zh_tw&edition=fundamental","pubTime":"2026-08-01 08:14","pubTimestamp":1785543240,"startTime":"0","endTime":"0","summary":"8月1日 早安安徽7月27日晚，黟县宏村景区灯火璀璨，众多游客在此惬意游玩。7月29日，安徽首张脑机接口处方开出并在安徽医科大学第一附属医院成功完成手术，这也是国家药品监督管理局批准植入式脑机接口产品上市后的省内首例手术。2025年度中国网络文学影响力榜发布7月30日，“2025年度中国网络文学影响力榜”发布仪式在安徽百戏城举办。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-08-01/doc-inikufht0890066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655365114","title":"艾伯維2026年第二季度財報：免疫學與神經科學推動營收增長10.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655365114","media":"TradingKey中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655365114?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:51","pubTimestamp":1785498690,"startTime":"0","endTime":"0","summary":"艾伯维2026年第二季度营收169.90亿美元，同比增长10.2%；GAAP摊薄EPS为2.03美元，调整后EPS为3.65美元，免疫学与神经科学组合成为主要增长来源。","market":"us","thumbnail":"https://resource.tradingkey.com/cdn/images/article/news/stock10.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cdn/images/article/news/stock10.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/earnings/262067442-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNTL","PSET","IBRN","SQMX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}